Evidence map›Paper›PMID 33313690›Full record

ArticleBrain : a journal of neurology2021

COVID-19 vaccine and Guillain-Barré syndrome: let's not leap to associations.

Michael P Lunn, David R Cornblath, Bart C Jacobs, Luis Querol, Peter A van Doorn, Richard A Hughes, Hugh J Willison

Abstract readComment
In one paragraph

Article in Brain : a journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Guillain-Barré syndrome.Nature reviews. Disease primers · 2024
    Article
  5. Review
  6. Article
  7. Early-onset Cervical Myelitis after COVID-19 Vaccination.Internal medicine (Tokyo, Japan) · 2023
    Article
  8. Review
  9. Article
  10. Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2022
    Article
  11. Article
  12. Article
  13. LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination.Neurological research and practice · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Michael P Lunn1 Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.
David R Cornblath3 Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Bart C Jacobs4 Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Luis Querol6 Department of Neurology, Hospital de la Santa Creu I Santa Pau, 8025, Barcelona, Spain.
Peter A van Doorn4 Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Richard A Hughes1 Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.
Hugh J Willison7 College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Guillain-Barre SyndromeCOVID-19 VaccinesHumansSARS-CoV-2COVID-19 Vaccines

Identifiers

PMID33313690
PMCPMC7799242

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.